Summary
The product Salbutamol 8 mg, manufactured by Unique Pharma, underwent independent testing to confirm its authenticity and potency. The sample, identified by batch number GH65721K, was submitted by the reseller Opitropin.EU and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Salbutamol, with a concentration of 8.63 mg, slightly above the labeled claim of 8 mg by +7.88%.
The testing process began on 01 August 2022, with the sample received on 09 August 2022, and analysis completed on 12 August 2022. While the results confirm relatively accurate dosing, minor deviations from the label raise questions about manufacturing consistency. This report is intended as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Unique Pharma
- Product Name: Salbutamol 8 mg
- Active Ingredient: Salbutamol
- Batch Number: GH65721K
- Expiration Date: Not provided
- Delivery Method: Oral Tablet
Sample Acquisition and Testing
- Task Number: #22600
- Testing Ordered: 01 August 2022
- Sample Received: 09 August 2022
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Opitropin.EU (Reseller)
- Analysis Paid For By: Opitropin.EU
Testing Results
- Specification: 8 mg (as stated on the label)
- Measured Concentration: 8.63 mg
- Accuracy: 107.88% (+0.63 mg above label claim)
- Variance: 7.88%
Verification Details
- Verification URL: https://janoshik.com/tests/22600_MD3DQ8PR1P1L
- Originally Published: https://thinksteroids.com/community/posts/3118518/
Evaluation of Reseller-Submitted Testing
This analysis confirms the presence and slight over-dosing of the active ingredient in the tested product, which could have implications for users sensitive to variations in dosage. Given that the testing was initiated and funded by the reseller, further independent third-party validation across multiple batches is recommended to assess consistency and ensure consumer safety.
Conclusion
The analysis indicates that Salbutamol 8 mg by Unique Pharma is slightly overdosed, with a measured concentration of 8.63 mg, reflecting good but not perfect quality control. Consumers should remain vigilant and consider third-party verification for assurance. This report aims to support educational and harm reduction efforts, helping users make informed choices regarding salbutamol use.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-submitted testing may introduce biases; however, it still provides valuable insights when critically evaluated alongside independent third-party results. Readers are encouraged to use this information responsibly.
